Annual Reports

Browse

Browsing Annual Reports by Title

Now showing 1 - 20 of 28
  • Thumbnail Image
    Item
    2010-2015 corporate plan
    (Australian Nuclear Science and Technology Organisation, 2010-09-01) Australian Nuclear Science and Technology Organisation
    Nuclear science and technology is a dynamic area of endeavour that focuses on the basic building blocks of matter at the atomic and sub-atomic level. It has many uses, including helping to gain a better understanding of both biological and physically complex systems, and in improving our quality of life. Nuclear science and technology’s potential to improve our lives and unlock the many mysteries of science is well established, but new and exciting areas are still open for innovation. This document details ANSTO’s Corporate Plan (the Plan) for the period 2010-2015, in particular: Our vision, purpose and core values A contextual overview of nuclear science and technology Findings from strategic and operational reviews undertaken over the past two years Strategic priorities for 2010-2015 How we will measure our success in implementing the Plan. Key external documents that have informed development of the Plan include: Statement of Expectations for the Australian Nuclear Science and Technology Organisation (Minister for Innovation, Industry, Science and Research) Australia’s National Research Priorities Powering Ideas: An Innovation Agenda for the 21st Century National Security Science and Innovation Strategy Inspiring Australia: A National Strategy for Engagement with the Sciences Australian Nuclear Science and Technology Organisation Act 1987. Internal documents include ANSTO’s: 2030 Scenario Planning Research Papers (2010) 2055 Infrastructure Plan (2010) ANSTO Statement of Intent (2010).
  • Thumbnail Image
    Item
    Annual report 2019 - 2020
    (Australian Nuclear Science and Technology Organisation, 2020-10-26) Australian Nuclear Science and Technology Organisation
    ANSTO leverages great science to deliver big outcomes. ● We partner with scientists and engineers and apply new technologies to provide real-world benefits. ● Our work improves human health, saves lives, builds our industries and protects the environment. ANSTO is the home of Australia’s most significant landmark and national infrastructure for research including the Open Pool Australian Light-water (OPAL) multi-purpose nuclear reactor, the Australian Synchrotron, the Centre for Accelerator Science (CAS), the Australian Centre for Neutron Scattering (ACNS) and the National Deuteration Facility (NDF). Every year, thousands of scientists from industry and academia benefit from gaining access to these stateof-the-art facilities. As part of enabling a strong national collaborative network, ANSTO is connected with 40 Australian and New Zealand universities through the Australian Institute of Nuclear Science and Engineering (AINSE), providing researchers with access to Australia’s nuclear science, technology and engineering expertise and national infrastructure which, in turn, facilitates greater national science collaboration. ANSTO has nearly 50 bilateral international memoranda of understanding (MOU) agreements with worldleading research institutes and universities that ensure that Australian scientists are well placed to drive innovation for Australia. These important partnerships give Australian scientists access to some of the world’s most sophisticated research techniques, enabling discoveries that benefit both Australia and the world. ANSTO’s nuclear medicines benefit thousands of Australians every week, supporting the accurate diagnosis of heart disease, skeletal conditions and cancer. Australia has a strong international role in nuclear science and technology through ANSTO. As a member of the International Atomic Energy Agency (IAEA) Board of Governors, Australia is committed to the peaceful application of nuclear science and technology. ANSTO’s long-term partnership with the IAEA has given our country important global responsibilities and recognition. ANSTO has two main campuses at Lucas Heights in New South Wales and Clayton in Victoria. ANSTO also works from and operates a facility in Camperdown in New South Wales.
  • Thumbnail Image
    Item
    Annual report 2020-2021
    (Australian Nuclear Science and Technology Organisation, 2021-10) Australian Nuclear Science and Technology Organisation
    This annual report provides a summary of our activities and performance for the financial year ending 30 June 2021 against the performance measures in our 2020–2021 Corporate Plan and Portfolio Budget Statements.
  • Thumbnail Image
    Item
    ANSTO annual report 1999-00.
    (Australian Nuclear Science and Technology Organisation, 2000)
    The period from July 1999 to June 2000 has, yet again, been both exciting and challenging. Our most important project is the Replacement Research Reactor Project - important not only for the future of the Organisation but also for the maintenance and development of a range of scientific and technological expertise that will underpin Australia's socio-economic development in the knowledge era. In August 1999 this project received unanimous approval from the bipartisan Public Works Committee. ANSTO immediately released the Request for Tender to the four prequalified vendors. All vendors, in alliance or partnership with Australian engineering companies, submitted proposals on the closing date of January 3rd, 2000. These proposals were reviewed and evaluated by internal and external experts, culminating in the final recommendation that INVAP SE, in alliance with John Holland Construction and Engineering Pty Ltd and Evans Deakin Industries Limited, be awarded the contract for the detailed engineering design, construction and commissioning of the replacement research reactor at the Lucas Heights Science and Technology Centre. After obtaining all relevant approvals, the contract was signed early in July and marked by a ceremony involving many of the people who had contributed to the process. The tender selection process was audited from start to finish and the relevant audit and review reports posted on ANSTO's website as part of our community advice. As this Annual Report goes to press the project is well underway. ANSTO staff are to be commended for their professionalism and dedication throughout the replacement research reactor project to date. They have worked tirelessly and met all major milestones under their control. It was heartening to learn that our comprehensive and independently audited consultation program during the environmental assessment phase of the replacement research reactor project was acclaimed by two awards from the Public Relations Institute of Australia. All of us at ANSTO appreciate the very considerable support and encouragement we have received from government, individuals, companies and professional societies across the science, engineering, medical and policy spectra. We look forward to working with our stakeholders to ensure that the scientific instruments developed for the various beamlines on the reactor are capable of delivering world class outcomes. During the past year current ANSTO's core nuclear facilities have been in strong demand. Staff and students from universities across Australia have accessed the facilities through AINSE, there being around 160 AINSE-supported university projects in the past year. ANSTO staff not only facilitate the execution of these projects but also undertake research to underpin other important elements of ANSTO's mission. Such projects are frequently carried out in collaboration with national and international teaming partners.
  • Thumbnail Image
    Item
    ANSTO annual report 2000-01
    (Australian Nuclear Science and Technology Organisation, 2001) The Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation. It has a staff of approximately 800 and is located at the Lucas Heights Science and Technology Centre, some 40 km south west of Sydney city centre. The science and technology centre occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO operates Australia’s only nuclear reactor, the research reactor HIFAR (which stands for High Flux Australian Reactor). The reactor is used to produce radioactive products for use in medicine and industry. It is also used extensively as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. The organisation also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. The facility is located in the grounds of the Royal Prince Alfred Hospital in Camperdown, an inner west suburb of Sydney. ANSTO provides the broad range of technical expertise needed to support Australia’s nuclear interests. It advises the Commonwealth Government on issues associated with the nuclear fuel cycle and the operation of nuclear facilities and it supports industry through the development and application of nuclear science based technology and associated capabilities. ANSTO organises its activities under six core business areas. Safety and environmental protection arrangements at ANSTO facilities are reported against separately. Further information about the organisation is available on ANSTO’s web site at www.ansto.gov.au.
  • Thumbnail Image
    Item
    ANSTO annual report 2001-02
    (Australian Nuclear Science and Technology Organisation, 2002) Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. It does so through the development of new knowledge, delivery of quality services and support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. The organisation also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. This is located in the grounds of the Royal Prince Alfred Hospital in Camperdown, close to Sydney’s central business district. ANSTO has a salaried staff of approximately 850. Its main site is located at the Lucas Heights Science and Technology Centre (LHSTC), 40 km south west of Sydney’s central business district. The LHSTC occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    ANSTO annual report 2002-03
    (Australian Nuclear Science and Technology Organisation, 2003) Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development (R&D) organisation and the centre of Australian nuclear expertise. With a salaried staff of approximately 830, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, delivery of quality services and support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. ANSTO also operates the National Medical Cyclotron (NMC), an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. It is located in the grounds of the Royal Prince Alfred Hospital in Camperdown. Located at the Lucas Heights Science and Technology Centre (LHSTC), 40 km south west of Sydney’s central business district, ANSTO’s main site occupies 70 hectares, surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    ANSTO annual report 2003-04
    (Australian Nuclear Science and Technology Organisation, 2004)
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With a salaried staff of approximately 830, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, delivery of quality services and support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor, HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. It is located in the grounds of the Royal Prince Alfred Hospital in Camperdown. Located at the Lucas Heights Science and Technology Centre (LHSTC), 40 km south west of Sydney’s central business district, ANSTO’s main site occupies 70 hectares, surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    ANSTO annual report 2004-05
    (Australian Nuclear Science and Technology Organisation, 2005) The Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With approximately 860 staff, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, the delivery of quality services and the provision of support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. A replacement for HIFAR, OPAL – the Open Pool Australian Light-water reactor – is in its final stages of construction. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. It is located in the grounds of the Royal Prince Alfred Hospital in Camperdown. ANSTO also manages access to overseas synchrotron facilities for Australian scientists. ANSTO’s main site is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and is translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    ANSTO annual report 2005-06
    (Australian Nuclear Science and Technology Organisation, 2006) The Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With approximately 860 staff, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, the delivery of quality services and the provision of support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. A replacement for HIFAR, OPAL – the Open Pool Australian Light-water reactor – is in its commissioning phase. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. ANSTO also manages access to overseas synchrotron facilities for Australian scientists. ANSTO’s main site is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and is translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    ANSTO annual report 2006-07
    (Australian Nuclear Science and Technology Organisation, 2007) The Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With approximately 950 staff, ANSTO is responsible for delivering specialised advice, scientific services and products togovernment, industry, academia and other research organisations. We do so through the development of new knowledge, the delivery of quality services and the provision of support for business opportunities. ANSTO’s nuclear infrastructure includes the Open Pool Australian Light-water reactor (OPAL), Australia’s new $470 million research reactor, particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. OPAL is Australia’s only operating nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. The High Flux Australian Reactor (HIFAR), which was Australia’s first reactor, was officially shut down in January 2007 and is currently awaiting decommissioning. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce short-lived radioisotopes for nuclear medicine procedures. ANSTO also manages access to overseas synchrotron facilities for Australian scientists. ANSTO’s main site is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. The Organisation’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and is translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    ANSTO annual report 2007-08
    (Australian Nuclear Science and Technology Organisation, 2008) Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and is the centre of Australian nuclear expertise. ANSTO operates Australia’s nuclear research reactor OPAL. OPAL is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. ANSTO’s nuclear infrastructure also includes particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. ANSTO’s main site is located 40 kilometres south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 kilometre buffer zone. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce short-lived radioisotopes for nuclear medicine procedures. The cyclotron is situated at the Royal Prince Alfred Hospital in Camperdown, Sydney. The organisation’s functions are prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and are translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    ANSTO annual report 2008-09
    (Australian Nuclear Science and Technology Organisation, 2009) Australian Nuclear Science and Technology Organisation
    ANSTO is Australia’s national nuclear research and development organisation and is the centre of Australian nuclear expertise. It is part of the Australian Government portfolio of Innovation, Industry, Science and Research. ANSTO undertakes research in the applications of nuclear science and technology and delivers specialised advice, scientific services and products to government, universities, other research organisations, international organisations and businesses in areas as diverse as mining and radiopharmaceuticals. About one-third of ANSTO’s staff are involved in research. The balance are in business services, operations and support to government roles. ANSTO operates Australia’s nuclear research reactor OPAL which is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. ANSTO’s research infrastructure also includes accelerators, cyclotrons and associated instruments as well as workshops, pilot plants and specialist laboratories. ANSTO’s research infrastructure is used extensively by other members of the Australian and international research communities including researchers from universities, other science and technology organisations and industry. ANSTO also manages the Access to Major Research Facilities Program (AMRFP), which provides Australian researchers with access to major international facilities. ANSTO’s main campus is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. The organisation’s functions are prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and are translated into action through its strategic and annual planning process.
  • Thumbnail Image
    Item
    ANSTO annual report 2009-10
    (Australian Nuclear Science and Technology Organisation, 2010-10) Australian Nuclear Science and Technology Organisation
    ANSTO is Australia’s national nuclear science and technology organisation and represents a concentration of Australia’s best nuclear science capabilities. It is part of the Australian Government portfolio of Innovation, Industry, Science and Research. ANSTO provides policy advice to the Australian Government in relation to all matters within the ambit of nuclear science and technology. In addition, ANSTO maintains critical capabilities to support government in undertaking its regional and international role and obligations in relation to nuclear science and technology. Research and innovation are central to ANSTO’s mission and mandate. Key outcomes include: research publications; the securing of intellectual property; training of research students; software development; engineering designs and demonstrators and engineering services; pilot plants and industrial consultancy for clients. We also license technology that arises from our innovation activities. ANSTO provides local and global partners with access to its research and innovation infrastructure to leverage their own research and innovation activities. This collaboration considerably expands the opportunity for the development of locally and globally significant research that will benefit all. ANSTO manufactures products and provides specialised services for customers. These commercial activities draw on ANSTO’s scientists and engineers to develop new products and manufacturing approaches and enhance product quality. Our businesses are focussed on the health of Australians, particularly in the application of radioisotopes for imaging and therapy; the application of mineral processing for naturally occurring radioactive materials; safe treatment and disposition of nuclear waste; and specialised irradiation services. ANSTO is the custodian of landmark infrastructure deployed in the national interest. ANSTO operates Australia’s OPAL multipurpose research reactor. Research reactors are essentially ‘neutron factories’. The neutrons are used for scientific research, the production of radioisotopes used in medicine, activating targets (such as mineral samples for research) and modifying the conductivity of single crystal silicon used for microelectonics. Complementing the OPAL reactor are particle accelerators which are part of the essential toolkit used for precisely dating geological samples, studying the history of climate variability, and materials research, among other applications. ANSTO is a leader in pilot plant design, operation and management for the mining industry. These plants are a significant factor in transferring laboratory results to industry and providing industry with greater confidence prior to full-scale plant development.
  • Thumbnail Image
    Item
    ANSTO annual report 2010-2011
    (Australian Nuclear Science and Technology Organisation, 2011-10-05) Australian Nuclear Science and Technology Organisation
    ANSTO – the Australian Nuclear Science and Technology Organisation – is home to Australia’s nuclear expertise. ANSTO employs over 1,100 people in southwest Sydney, and supplies Australia with outstanding nuclear research, medicine and technology capabilities. The organisation provides policy advice to Government on all matters relating to nuclear science, technology and engineering. It supports Government in undertaking its international roles and obligations. It also undertakes research and pursues innovation in areas aligned with the national research priorities and those that have the potential to deliver key outcomes to support Australians and Australian industry. ANSTO strives to achieve key outcomes in publishing scientific research, securing intellectual property, training research students, developing software, providing engineering design and services, and consulting for industry. Innovation is critical to increasing Australia’s productivity and competitiveness. The Australian Government invested over $9 billion in science research and innovation in the 2010-2011 financial year and this investment is evident through the landmark science infrastructure Australian scientists can now access at ANSTO.
  • Thumbnail Image
    Item
    ANSTO annual report 2011-2012
    (Australian Nuclear Science and Technology Organisation, 2012-11-01) Australian Nuclear Science and Technology Organisation
    For over 50 years, the Australian Nuclear Science and Technology Organisation (ANSTO) has proudly been the home to Australia’s nuclear expertise. Nuclear science and technology is a dynamic and exciting area of endeavour that focuses on the basic building blocks of matter at the atomic level. Many of the most important questions facing society today are within the domain of ANSTO’s expertise; whether in the area of health, climate change or driving innovation for industry. ANSTO’s state-of-the-art research facilities and our connection with other local and international research centres, means our scientists have the resources and networks to make a significant contribution today and in the future. Central to realising the capabilities of some of Australia’s significant science infrastructure are our people – ANSTO has over 1,100 dedicated scientists, engineers and support staff who strive daily to exploit the opportunities nuclear science and technology offers, for the benefit of all Australians. As a Federal Government agency, ANSTO provides advice to the Federal Government on all matters relating to nuclear science, technology and engineering. ANSTO supports Australia’s international roles and obligations, contributing to nuclear non-proliferation and participating in international decision making, keeping Australia at the forefront of nuclear science and technology. At the heart of ANSTO’s research capabilities is the OPAL reactor which is one of the world’s best multi-purpose research reactors. OPAL is used for scientific research, the production of medical radioisotopes, and the irradiation of silicon used in microelectronics in superfast trains and hybrid cars. OPAL facilitates specialised research using a growing suite of neutron beam instruments at ANSTO’s Bragg Institute where scientists apply neutron scattering and X-ray techniques to solve complex research and industrial problems such as developing renewable, clean energy technologies. ANSTO also operates two particle accelerators, STAR and ANTARES, which are used to analyse materials to determine their elemental composition and age, and are fundamental to advancing knowledge in areas as important as climate change. Development of the Federal Government funded Centre for Accelerator Science at ANSTO, is now well underway. The new Centre will attract local and international scientists from a wide range of scientific disciplines working in areas such as radiocarbon dating and environmental studies, which are key in understanding past human activity (eg. rock art) and climate variability.
  • No Thumbnail Available
    Item
    ANSTO Research Highlight 2009-2009, Institute of Materials Engineering
    (Australian Nuclear Science and Technology Orgaisation, 2012-02) Australian Nuclear Science and Technology Orgaisation Institute of Materials Engineering
    This document contains a brief description of the research and operational highlights of Institute of Materials Engineering and a list of the published research outputs for the years 2007-2009 representing the first half of the period covered by the present review. The highlights are presented using a modified Frascati representation, which is presently used by ANSTO to classify its research.
  • Thumbnail Image
    Item
    ANSTO research impact report : covers highlights from the period 2016-2022 at ANSTO
    (Australian Nuclear Science and Technology Organisation, 2023-11) Australian Nuclear Science and Technology Organisation
    The Research Impact Report shows some of the many ways that science at ANSTO has delivered real world benefits in recent years. It is important not only to do great science but to be seen to be doing great science, so we deliver this report in the spirit of accountability: to the government; to other funders and supporters who made this research possible; and to the public, who ultimately reap the rewards. The case studies presented in the report deliver benefit and represent a significant intellectual achievement from ANSTO scientists in collaboration with users, partners, and industry clients. Our research, and the research of those who access our infrastructure, relies on nuclear science and technology that can only be delivered by ANSTO. Science at ANSTO brings public benefit to all Australians, in areas of national priority and in alignment with national science and research priorities, through innovation for industry, improving health, protecting the environment, optimising the nuclear fuel cycle, supporting Indigenous cultural heritage, enhancing food and agriculture, and fostering discovery. When you browse through this library of almost a hundred case studies, you will also find details of ANSTO’s advanced capabilities, and, importantly, a list of the individuals who contributed to the research. Whether it is coming up with the concept or theory, conducting the experiment, interpreting the results or translating the science into a technology, the effort is a shared one. We applaud these efforts and celebrate the achievements captured in the case studies. At a time when excellent science is needed to help resolve opportunities and challenges for the nation, ANSTO is proud to have delivered on its mandate in delivering knowledge and advancing prosperity for the benefit of Australia.
  • Thumbnail Image
    Item
    ANSTO research infrastructure decadal plan 2022-2032
    (Australian Nuclear Science and Technology Organisation, 2022-01) Australian Nuclear Science and Technology Organisation
    The ANSTO research infrastructure portfolio comprises capital investment in the region of AU $1 billion, more than 350 employees and contractors, and an extensive array of operating systems and procedures that supported more than 8,000 users over the 2019-2021 period. As we enter the second decade of the 21st century and global and domestic challenges are clearly identified, it is essential that the excellence of ANSTO’s capabilities is sustained and benefit to the nation remains front of mind. In the context of nuclear science and technology, there is now a range of nationally significant programs that will be developed over the course of the next ten years. These include the establishment of a national radioactive waste management facility by the Australian Radioactive Waste Authority (ARWA) and the design, build and operation of a new nuclear medicine manufacturing facility at Lucas Heights. The biggest “game changer”, however, will be the establishment of a nuclear powered submarine fleet for the Royal Australian Navy along with all associated technologies and capabilities. Maximising utilisation, continuous improvement and predictable operation of infrastructure, together with developing expert staff who are focused on research support, is critical to strengthening the science and technology standing of the nation. With a long and successful track record, ANSTO has the demonstrated capability to inform and support long range planning for future landmark and national capabilities. To this end, this document is ANSTO’s first Research Infrastructure Decadal Plan. This Decadal Plan was developed in consultation with our staff, users, partners and clients. It considers the environment within which ANSTO, as a Publicly Funded Research Agency (PFRA), operates and was informed by current and emerging science, research, policy, innovation challenges, as well as technology drivers. It is aligned and coincides with the Commonwealth Government’s 2021 National Research Infrastructure Roadmap process. The value of long-term strategic planning of research infrastructure of any scale has been demonstrated for many years. The benefits include planned strategic investment into facilities that enable research across priority areas, predictable funding to sustain operations, and investment in workforce to drive utilisation, impact and benefits. Much of ANSTO’s multi-disciplinary research infrastructure has evolved over many decades in line with changing research drivers and needs inside and outside ANSTO. The Decadal Plan looks towards future development and invites us to keep scanning the horizon for opportunities beyond the next decade. Growing, developing, and improving our research infrastructure happens deliberately and with intent. The Decadal Plan recognises this and seeks to understand the drivers that will spur our growth. It expresses those drivers through priority areas where we need to focus our efforts over the next ten years and allows us to plan our development to achieve sustainable funding. Our people are core to our infrastructure. The Decadal Plan brings ANSTO’s people into focus to support them in growing together across our buildings and campuses, recognises the unique contribution they make, and nurtures their growth and development. ANSTO’s research infrastructure is embedded in Australia’s scientific infrastructure framework, including strategic planning of national capabilities and connects us to the world with high visibility. The Decadal Plan sets us on a path to increase this visibility and provides a roadmap for our future growth and development, enabling the ANSTO Vision to be achieved by positioning ANSTO as key to Australia’s research and innovation ecosystem.
  • Thumbnail Image
    Item
    ANSTO the first 10 year of the Bragg Institute 2002-2012
    (Australian Nuclear Science and Technology Organisation, 2013-03) Australian Nuclear Science and Technology Organisation
    It is a great pleasure to introduce this wonderful compilation of the achievements of the Bragg Institute during its first 10 years, told by the people who were involved in developing the Institute from its very beginnings. In 2013, ANSTO is celebrating its 60th anniversary. The achievements of our organisation over the past six decades have been bolstered tremendously by the many successes of our Bragg Institute. ANSTO’s Bragg Institute has established itself as one of Australia’s most significant scientific user platforms, with seven operating neutron beam instruments having been successfully constructed and commissioned, with a further six instruments under development. The Institute has also established a world-leading National Deuteration Facility that supports specialised research based on the distinct neutron scattering from hydrogen and deuterium. Researchers from 137 Australian and international research organisations have used the neutron beam instruments over the past 10 years, with over a thousand research articles being published in a range of high-quality journals. Enabled by OPAL, one of the world’s most modern research reactors, Bragg is well placed to continue to support research for many more decades to come. I trust you will enjoy the individual stories of the people behind developing, installing and running the instruments. They have shared their achievements, challenges and insights for the exciting future that is ahead for the Bragg Institute. I wish to extend my appreciation to our users and collaborators for their ongoing support. Although it is sometimes inappropriate to single out individuals, I want to extend my personal thanks to Rob Robinson, who has built and steered the Institute over the first decade. I congratulate all of our people, both past and present, who have contributed to the success of the Bragg Institute.